United States · FDA National Drug Code directory
Bupropion hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2499_1a76f460-218f-4e30-a86c-7b47120b5ecd
- Product NDC
- 71335-2499
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Bupropion hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221215
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-1) · 71335-2499-1
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-2) · 71335-2499-2
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-3) · 71335-2499-3
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-4) · 71335-2499-4
- 8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-5) · 71335-2499-5
- 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-6) · 71335-2499-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →